Global Contraceptives Market 2026 -
Players, Regions, Product Types, Application & Forecast Analysis
Global Contraceptives Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis
| Pharma & Healthcare | Formats |
| Updated: March 2026 | 4.6 (86) |
Chapter 1 Contraceptives Market Overview
1.1 Contraceptives Definition
1.2 Global Contraceptives Market Size Status and Outlook (2019-2032)
1.3 Global Contraceptives Market Size Comparison by Region (2019-2032)
1.4 Global Contraceptives Market Size Comparison by Type (2019-2032)
1.5 Global Contraceptives Market Size Comparison by Application (2019-2032)
1.6 Global Contraceptives Market Size Comparison by Sales Channel (2019-2032)
1.7 Contraceptives Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)
1.7.4 COVID-19 Impacts
1.7.5 Russia-Ukraine War Impacts
1.7.6 US-Israel-Iran War Impacts
Chapter 2 Executive Summary
2.1 Global Contraceptives Market Snapshot
2.2 Global Contraceptives Market Volume & Revenue (2019-2025)
2.3 Global Contraceptives Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)
2.4 Global Contraceptives Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)
2.5 Global Contraceptives Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)
2.6 Global Contraceptives Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)
Chapter 3 Contraceptives Market Segment Analysis by Player
3.1 Global Contraceptives Sales and Market Share by Player (2023-2025)
3.2 Global Contraceptives Revenue and Market Share by Player (2023-2025)
3.3 Global Contraceptives Average Price by Player (2023-2025)
3.4 Players Competition Situation & Trends (2023-2025)
3.5 Conclusion of Segment by Player
Chapter 4 Contraceptives Market Segment Analysis by Type
4.1 Global Contraceptives Market by Type
4.1.1 Prolonged Contraception
4.1.2 Short-term Contraception
4.1.3 Emergency Contraception
4.2 Global Contraceptives Sales and Market Share by Type (2019-2025)
4.3 Global Contraceptives Revenue and Market Share by Type (2019-2025)
4.4 Global Contraceptives Average Price by Type (2019-2025)
4.5 Leading Players of Contraceptives by Type in 2025
4.6 Conclusion of Segment by Type
Chapter 5 Contraceptives Market Segment Analysis by Application
5.1 Global Contraceptives Market by Application
5.1.1 Hospital Pharmacies
5.1.2 Retail Pharmacies
5.1.3 Others
5.2 Global Contraceptives Revenue and Market Share by Application (2019-2025)
5.3 Leading Consumers of Contraceptives by Application in 2025
5.4 Conclusion of Segment by Application
Chapter 6 Contraceptives Market Segment Analysis by Sales Channel
6.1 Global Contraceptives Market by Sales Channel
6.1.1 Global Contraceptives Market, by Direct Channel Market Analysis (2019-2032) (USD Million)
6.1.2 Global Contraceptives Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)
6.2 Global Contraceptives Revenue and Market Share by Sales Channel (2019-2025)
6.3 Leading Distributors/Dealers of Contraceptives by Sales Channel in 2025
6.4 Conclusion of Segment by Sales Channel
Chapter 7 Contraceptives Market Segment Analysis by Region
7.1 Global Contraceptives Market Size and CAGR by Region (2019-2032)
7.2 Global Contraceptives Sales and Market Share by Region (2019-2025)
7.3 Global Contraceptives Revenue and Market Share by Region (2019-2025)
7.4 North America
7.4.1 North America Market by Country
7.4.2 North America Contraceptives Market Share by Type
7.4.3 North America Contraceptives Market Share by Application
7.4.4 United States
7.4.5 Canada
7.4.6 Mexico
7.5 Europe
7.5.1 Europe Market by Country
7.5.2 Europe Contraceptives Market Share by Type
7.5.3 Europe Contraceptives Market Share by Application
7.5.4 Germany
7.5.5 United Kingdom
7.5.6 France
7.5.7 Italy
7.5.8 Russia
7.5.9 Spain
7.5.10 Benelux
7.5.11 Poland
7.5.12 Austria
7.5.13 Portugal
7.5.14 Rest of Europe
7.6 Asia-Pacific
7.6.1 Asia-Pacific Market by Country
7.6.2 Asia-Pacific Contraceptives Market Share by Type
7.6.3 Asia-Pacific Contraceptives Market Share by Application
7.6.4 China
7.6.5 Japan
7.6.6 Korea
7.6.7 India
7.6.8 Southeast Asia
7.6.9 Australia
7.6.10 Taiwan
7.6.11 Rest of Asia Pacific
7.7 South America
7.7.1 South America Market by Country
7.7.2 South America Contraceptives Market Share by Type
7.7.3 South America Contraceptives Market Share by Application
7.7.4 Brazil
7.7.5 Argentina
7.7.6 Colombia
7.7.7 Chile
7.7.8 Peru
7.7.9 Venezuela
7.7.10 Rest of South America
7.8 Middle East & Africa
7.8.1 Middle East & Africa Market by Country
7.8.2 Middle East & Africa Contraceptives Market Share by Type
7.8.3 Middle East & Africa Contraceptives Market Share by Application
7.8.4 UAE
7.8.5 Saudi Arabia
7.8.6 South Africa
7.8.7 Egypt
7.8.8 Nigeria
7.9.9 Rest of Middle East & Africa
7.9 Conclusion of Segment by Region
Chapter 8 Profile of Leading Contraceptives Players
8.1 Bayer
8.1.1 Company Snapshot
8.1.2 Product/Service Offered
8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.1.4 Recent Developments
8.2 Pfizer
8.2.1 Company Snapshot
8.2.2 Product/Service Offered
8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.2.4 Recent Developments
8.3 Teva Pharmaceutical
8.3.1 Company Snapshot
8.3.2 Product/Service Offered
8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.3.4 Recent Developments
8.4 Merck
8.4.1 Company Snapshot
8.4.2 Product/Service Offered
8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.4.4 Recent Developments
8.5 Actavis
8.5.1 Company Snapshot
8.5.2 Product/Service Offered
8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.5.4 Recent Developments
8.6 Johnson & Johnson
8.6.1 Company Snapshot
8.6.2 Product/Service Offered
8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.6.4 Recent Developments
8.7 Gedeon Richter
8.7.1 Company Snapshot
8.7.2 Product/Service Offered
8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.7.4 Recent Developments
8.8 Novo Nordisk
8.8.1 Company Snapshot
8.8.2 Product/Service Offered
8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.8.4 Recent Developments
8.9 Mayer Laboratories
8.9.1 Company Snapshot
8.9.2 Product/Service Offered
8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.9.4 Recent Developments
8.10 Reckitt Benckiser
8.10.1 Company Snapshot
8.10.2 Product/Service Offered
8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.10.4 Recent Developments
8.11 Church & Dwight
8.11.1 Company Snapshot
8.11.2 Product/Service Offered
8.11.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.11.4 Recent Developments
8.12 Allergan
8.12.1 Company Snapshot
8.12.2 Product/Service Offered
8.12.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.12.4 Recent Developments
8.13 Afaxys
8.13.1 Company Snapshot
8.13.2 Product/Service Offered
8.13.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.13.4 Recent Developments
8.14 Agile Therapeutics
8.14.1 Company Snapshot
8.14.2 Product/Service Offered
8.14.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.14.4 Recent Developments
8.15 Apothecus Pharmaceutical
8.15.1 Company Snapshot
8.15.2 Product/Service Offered
8.15.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.15.4 Recent Developments
8.16 Mithra Pharmaceuticals
8.16.1 Company Snapshot
8.16.2 Product/Service Offered
8.16.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.16.4 Recent Developments
8.17 Zizhu Pharmaceutical
8.17.1 Company Snapshot
8.17.2 Product/Service Offered
8.17.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.17.4 Recent Developments
8.18 Baijingyu
8.18.1 Company Snapshot
8.18.2 Product/Service Offered
8.18.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.18.4 Recent Developments
8.19 Huazhong
8.19.1 Company Snapshot
8.19.2 Product/Service Offered
8.19.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.19.4 Recent Developments
8.20 Shanghai SINE
8.20.1 Company Snapshot
8.20.2 Product/Service Offered
8.20.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.20.4 Recent Developments
Chapter 9 Upstream and Downstream Analysis of Contraceptives
9.1 Industrial Chain of Contraceptives
9.2 Upstream of Contraceptives
9.2.1 Raw Materials (If Applicable)
9.2.2 Manufacturing Cost Structure (If Applicable)
9.2.3 Manufacturing Process (If Applicable)
9.3 Downstream of Contraceptives
9.3.1 Leading Distributors/Dealers of Contraceptives
9.3.2 Leading Consumers of Contraceptives
Chapter 10. Global Contraceptives Market Industry Analysis
10.1. Porter's Five Forces Analysis
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Buyers/Consumers
10.1.3. Bargaining Power of Suppliers
10.1.4. Threat of Substitute Types
10.1.5. Intensity of Competitive Rivalry
10.2. Major Growth Avenues within Global Contraceptives Market
10.2.1. Product Types
10.2.2. Applications
10.2.3. Sales Channels
10.2.4. Country
10.3. Contraceptives Industry Ecosystem
10.4. Price Trend Analysis (If Applicable)
10.5. Buying Criteria (If Applicable)
10.6. Regulations (If Applicable)
Chapter 11 Development Trend of Contraceptives (2026-2032)
11.1 Global Contraceptives Market Size (Sales and Revenue) Forecast (2026-2032)
11.2 Global Contraceptives Market Size and CAGR Forecast by Region (2026-2032)
11.3 Global Contraceptives Market Size and CAGR Forecast by Type (2026-2032)
11.4 Global Contraceptives Market Size and CAGR Forecast by Application (2026-2032)
11.5 Global Contraceptives Market Size and CAGR Forecast by Sales Channel (2026-2032)
Chapter 12. Import - Export Analysis (If Applicable)
12.1 North America Contraceptives Import-Export (2019-2025)
12.2 Europe Contraceptives Import-Export (2019-2025)
12.3 Asia Pacific Contraceptives Import-Export (2019-2025)
12.4 South America Contraceptives Import-Export (2019-2025)
12.5 Middle East & Africa Contraceptives Import-Export (2019-2025)
Chapter 13. Demand-Supply Gap Analysis
13.1 North America Contraceptives Demand-Supply (2019-2025)
13.2 Europe Contraceptives Demand-Supply (2019-2025)
13.3 Asia Pacific Contraceptives Demand-Supply (2019-2025)
13.4 South America Contraceptives Demand-Supply (2019-2025)
13.5 Middle East & Africa Contraceptives Demand-Supply (2019-2025)
Chapter 14 Appendix
14.1 Research Methodology
14.2 Data Sources
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.